Managing a patient with advanced isolated proctitis, a subtype of ulcerative colitis

Emerging evidence for S1P receptor modulators in ulcerative colitis

Positioning of new S1P receptor modulators to optimize patient outcomes in UC

C. diff: FMT and new microbiome therapies

JAK Inhibitors for Ulcerative Colitis: Conversations From the Clinic